GSK's Zejula racks up first-line ovarian cancer maintenance win by Eric Sagonowsky Monday, July 15, 2019 GlaxoSmithKline laid out $5.1 billion for Tesaro and its cancer med Zejula, and some new ovarian cancer data may help prove the deal was worth it.
BREAKING: GlaxoSmithKline snares ex-AZ, Novartis CFO as chairman by Angus Liu Monday, July 15, 2019 Jonathan Symonds, with plenty of experience in major life science deals, could be a strong fit for GSK as it looks to separate consumer health with pharma.
J&J-Hanmi, BI-Yuhan, GSK and more—FiercePharmaAsia by Angus Liu Friday, July 12, 2019 Hanmi loses Janssen obesity pact, while Yuhan signs NASH deal with Boehringer. GSK sells a Chinese site to Fosun as it opens facilities in Singapore.
Aiming for Gilead’s HIV lead, GSK touts Dovato switching data by Angus Liu Wednesday, July 10, 2019 At least based on recent IQVIA data, analysts suspect that Dovato will be of threat to Gilead any time soon.
Fosun snatches GSK plant in China by Eric Palmer Tuesday, July 9, 2019 Even as GlaxoSmithKline has opened its most advanced manufacturing site in Asia, it is selling an older plant in China to Fosun Pharma.
GSK opens $95M continuous production operation in Singapore by Eric Palmer Monday, July 8, 2019 GlaxoSmithKline has opened continuous manufacturing operations in Singapore that will make products faster, with less cost and less waste.
Pharma's got its CDOs. Now let's see results: Sanofi exec by Carly Helfand Tuesday, June 25, 2019 Sanofi’s chief digital officer isn’t surprised to see CDOs popping up across Big Pharma. But they have to earn their keep, he says.
GSK wins speedy FDA Zejula review in ovarian cancer niche by Eric Sagonowsky Monday, June 24, 2019 Late-stage ovarian cancer patients have few options, but now the FDA is reviewing GlaxoSmithKline's Zejula for the patient group.
GSK starts £1B OTC sell-off ahead of Pfizer merger: report by Angus Liu Thursday, June 20, 2019 GSK is grouping some non-core consumer products into three portfolios for sell-offs so it can win EU antitrust clearance for its Pfizer deal.
GSK digital chief strolls Lions Health for inspiration by Beth Snyder Bulik Thursday, June 20, 2019 GSK's consumer health chief digital officer Marc Speichert talks about the creative inspiration and partner opportunities at Lions Health.
